Alkermes Announces 2022 Alkermes Inspiration Grants® Program to Support Innovative Programs Focused on People Affected by Addiction, Serious Mental Illness or CancerPRNewsWire • 06/02/22
Alkermes Presents ARTISTRY-1 Data at 2022 American Society of Clinical Oncology (ASCO) Annual MeetingPRNewsWire • 06/01/22
Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D.PRNewsWire • 05/26/22
Sanofi, Regeneron's Dupixent Gets FDA Nod for 4th Indication (Revised)Zacks Investment Research • 05/25/22
Alkermes Announces Four Abstracts Accepted for Presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual MeetingPRNewsWire • 05/09/22
Alkermes to Highlight Data Related to Psychiatry Portfolio at Upcoming Scientific Conferences During Mental Health Awareness MonthPRNewsWire • 05/02/22
Alkermes' (ALKS) CEO Richard Pops on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 04/27/22